Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.09 +0.06 (+2.96%)
As of: Oct 22, 2026 · 11:19 AM EDT

Acumen Pharmaceuticals (ABOS) Return on Equity [ROE] (2021 - 2026)

Updated

Acumen Pharmaceuticals' Return on Equity [ROE] came in at -144.53% for Q2 2026, down 43.92 percentage points from -100.61% a year earlier and down 1.61 percentage points from the prior quarter.

Analysis

Acumen Pharmaceuticals (ABOS) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, Acumen Pharmaceuticals' Return on Equity [ROE] was -95.63%, down 49.38 percentage points from FY2024.

  • Return on Equity [ROE] has declined in each of the last four years, with a four-year change of -76.67 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Equity [ROE] was -46.24% in FY2024 (-23.89 pp), -22.35% in FY2023 (-0.49 pp), -21.86% in FY2022 (-2.90 pp) and -18.96% in FY2021.
  • The five-year range for quarterly Return on Equity [ROE] is -147.44% (Q4 2025) to -8.53% (Q4 2021).
  • Year-over-year, Return on Equity [ROE] has declined for eight consecutive quarters, with an average year-over-year change of -59.16 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2024 (a gain of 6.17 percentage points), and the weakest in Q4 2025 (a drop of 95.43 percentage points).
  • Business Quant data shows ABOS's Return on Equity [ROE] at -142.92% (Q1 2026), -147.44% (Q4 2025) and -126.79% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,172.45 Bn 1,141.04 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 637.59 Bn 556.11 Bn 17.26 Bn 25.32%
3 AbbVie 504.05 Bn 477.16 Bn 12.70 Bn -
4 Merck 377.18 Bn 331.56 Bn 12.21 Bn 7.21%
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn 31.52%
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn 21.39%
7 Amgen 241.83 Bn 197.23 Bn 7.24 Bn 83.75%
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn -18.38%
9 Pfizer 172.51 Bn 119.15 Bn 10.94 Bn 4.97%
10 Acumen Pharmaceuticals 151.00 Mn -331.07 Mn - -144.53%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -144.53%
Mar 31, 2026 -142.92%
Dec 31, 2025 -147.44%
Sep 30, 2025 -126.79%
Jun 30, 2025 -100.61%
Mar 31, 2025 -69.91%
Dec 31, 2024 -52.01%
Sep 30, 2024 -35.23%
Jun 30, 2024 -25.44%
Mar 31, 2024 -20.56%
Dec 31, 2023 -19.28%
Sep 30, 2023 -23.11%
Jun 30, 2023 -28.94%
Mar 31, 2023 -26.73%
Dec 31, 2022 -23.47%
Sep 30, 2022 -19.55%
Jun 30, 2022 -15.12%
Mar 31, 2022 -11.32%
Dec 31, 2021 -8.53%
Sep 30, 2021 -19.63%
API Access

Acumen Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ABOS&period=max&api_key=YOUR_API_KEY